Literature DB >> 12362272

The p53 network in lung carcinogenesis.

Ana I Robles1, Steven P Linke, Curtis C Harris.   

Abstract

The p53 tumor suppressor gene lies at the crossroads of multiple cellular response pathways that control a cell's fate in response to endogenous or exogenous stresses. Positive and negative regulatory loops both upstream and downstream of p53 cooperate to finely tune its functions as a transcription factor, a DNA damage sensor, and possibly, a protein-assembly scaffold. Through this plethora of activities, p53 is a major determinant of cell survival and a safeguard against genetic instability. Functional inactivation of p53 pathways through genetic and epigenetic events affecting the p53 gene itself and/or its interacting partners occur with a high frequency in lung cancer. The p53 mutational spectrum provides molecular evidence of the etiology of lung cancer and supports abundant epidemiological data indicating the role of tobacco smoke in the causation of this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12362272     DOI: 10.1038/sj.onc.1205563

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

Review 1.  Genetic changes in squamous cell lung cancer: a review.

Authors:  Rebecca S Heist; Lecia V Sequist; Jeffrey A Engelman
Journal:  J Thorac Oncol       Date:  2012-05       Impact factor: 15.609

2.  Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.

Authors:  Meredith A Tennis; Michelle M Van Scoyk; Scott V Freeman; Katherine M Vandervest; Raphael A Nemenoff; Robert A Winn
Journal:  Mol Cancer Res       Date:  2010-05-25       Impact factor: 5.852

3.  Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Xiang-Hua Ye; Zhi-Bin Bu; Jie Feng; Ling Peng; Xin-Biao Liao; Xin-Li Zhu; Xiao-Li Sun; Hao-Gang Yu; Dan-Fang Yan; Sen-Xiang Yan
Journal:  Mol Biol Rep       Date:  2013-11-23       Impact factor: 2.316

Review 4.  Ocular coloboma: a reassessment in the age of molecular neuroscience.

Authors:  C Y Gregory-Evans; M J Williams; S Halford; K Gregory-Evans
Journal:  J Med Genet       Date:  2004-12       Impact factor: 6.318

5.  Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study.

Authors:  Ana Souto-García; Ana Fernández-Somoano; Teresa Pascual; Sara M Álvarez-Avellón; Adonina Tardón
Journal:  Lung Cancer (Auckl)       Date:  2012-11-21

Review 6.  Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury.

Authors:  Edouard I Azzam; Jean-Paul Jay-Gerin; Debkumar Pain
Journal:  Cancer Lett       Date:  2011-12-17       Impact factor: 8.679

7.  From Physics to Pharmacology?

Authors:  Richard J Allen; Timothy C Elston
Journal:  Rep Prog Phys       Date:  2011-01

8.  Modulation of lung molecular biomarkers by beta-carotene in the Physicians' Health Study.

Authors:  Chun Liu; Xiang-Dong Wang; Lorelei Mucci; J Michael Gaziano; Shumin M Zhang
Journal:  Cancer       Date:  2009-03-01       Impact factor: 6.860

9.  Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore.

Authors:  Hui Wan Chua; Daniel Ng; Serena Choo; San San Lum; Huihua Li; Li Ying Soh; Kanaga Sabapathy; Adeline Seow
Journal:  BMC Cancer       Date:  2010-03-10       Impact factor: 4.430

10.  P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies.

Authors:  Shengming Dai; Chen Mao; Lijun Jiang; Guisheng Wang; Hongge Cheng
Journal:  Hum Genet       Date:  2009-04-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.